Pharmacy drivers: Caremark CEO Mac Crawford addresses the question of aligned incentives
Every organization is accountable to its stakeholders, and Caremark, the Nashville-based pharmacy benefit manager, is no exception. Caremark, however, is also accountable to its customers for clinical execution, so performance metrics are both wide and deep.
In the past year, the healthcare industry has come under scrutiny to be more accountable so those who pay for care can see what they're getting for their dollar-much the same way shareholders expect updates from the companies in which they own stock. Those who foot the bill are increasingly calling for reform, proven value, reduced waste, increased quality, aligned incentives and transparent models that justify prices.
Mac Crawford, CEO of Caremark, says the concept of transparency means different things to different people, but it's a question being raised about alignment of incentives between those who deliver healthcare and those who pay for it. He sees it as an evolution of the healthcare business-one he's been watching closely.
Employers, health plans and other payers have evolved their roles to become more price-conscious, Crawford says. Now, they've gone beyond just asking about out-of-pocket costs to ask for an understanding of cost drivers.
As for Caremark-recognized as the nation's second-largest PBM-it has to communicate to its customers how the incentives align, according to Crawford, lest it lose business. Customers want to know more, and Crawford says he has no problem sharing that.
"I've not had anybody tell me that they think we shouldn't make a reasonable return on investment and the assets it takes to run our business," he says. "I have had people say, 'help me understand where you make your money.'"
A Conversation With Greg Baker, RPh, CEO of AffirmedRx
March 31st 2024Greg Baker, CEO of AffirmedRx, describes his early career, shares some of his critical opinions about the pharmacy benefit management (PBM) industry and how, in his view, his company is offering a better alternative.
Read More
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
What Payers Need to Know As Retail Pharmacies Move Into Primary Care
September 6th 2023Healthcare beyond the doors of the doctor’s office has the potential to offer more care to more people. But payers need to think about how to ensure that care is consistent. Regardless of the setting, care decisions must be based on evidence-based content and supported with strong patient education.
Read More
